Is It Justifiable to Move the Grade-1 Ki67 Index Cut-Off from 3% to 5% for Pancreatic Neuroendocrine Tumors as Has Been Proposed? The Cases That Fall to 3-5% Category Have Clinicopathologic Characteristics Closer to Those > 5% | AVESİS

Marmara University Research Information System

Is It Justifiable to Move the Grade-1 Ki67 Index Cut-Off from 3% to 5% for Pancreatic Neuroendocrine Tumors as Has Been Proposed? The Cases That Fall to 3-5% Category Have Clinicopathologic Characteristics Closer to Those > 5%

Reid M., Balci S., BAĞCI ÇULÇİ P. , Saka B., Pehlivanoglu B., ERBARUT SEVEN İ. , ...More

109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Los-Angeles, Chile, 29 February - 05 March 2020, vol.33, pp.1673

Publication Type: Conference Paper / Summary Text
Volume: 33
City: Los-Angeles
Country: Chile
Page Numbers: pp.1673